Mutation Spectrum and Phenotypic Features in Noonan Syndrome with PTPN11 Mutations: Definition of Two Novel Mutations

Overview

Journal Indian J Pediatr

Specialty Pediatrics

Date 2016 Jan 29

PMID 26817465

Citations 6

Authors

Tahir Atik

Ayca Aykut

Filiz Hazan

Huseyin Onay

Damla Goksen

Sukran Darcan

Ajlan Tukun

Ferda Ozkinay

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate the spectrum of PTPN11 gene mutations in Noonan syndrome patients and to study the genotype-phenotype associations.

Methods: In this study, twenty Noonan syndrome patients with PTPN11 mutations were included. The patients underwent a detailed clinical and physical evaluation. To identify inherited cases, parents of all mutation positive patients were analyzed.

Results: Thirteen different PTPN11 mutations, two of them being novel, were detected in the study group. These mutations included eleven missense mutations: p.G60A, p.D61N, p.Y62D, p.Y63C, p.E69Q, p.Q79R, p.Y279C,p.N308D, p.N308S, p.M504V, p.Q510R and two novel missense mutations: p.I56V and p.I282M. The frequency of cardiac abnormalities and short stature were found to be 80 % and 80 %, respectively. Mental retardation was not observed in patients having exon 8 mutations. No significant correlations were detected between other phenotypic features and genotypes.

Conclusions: By identifying genotype-phenotype correlations, this study provides information on phenotypes observed in NS patients with different PTPN11 mutations.

Citing Articles

Spectrum of Mutations in in Russian Cohort.

Orlova A, Guseva D, Demina N, Polyakov A, Ryzhkova O Genes (Basel). 2024; 15(3).

PMID: 38540404 PMC: 10970286. DOI: 10.3390/genes15030345.

A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects.

Tabib A, Talebi T, Ghasemi S, Pourirahim M, Naderi N, Maleki M Eur J Med Res. 2022; 27(1):286.

PMID: 36496429 PMC: 9737984. DOI: 10.1186/s40001-022-00920-8.

Clinical features, genetic detection and therapeutic response to rhGH of children with Noonan syndrome: an analysis of 12 cases.

Shangguan H, Xu Y, Chen R Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021; 50(4):500-505.

PMID: 34704406 PMC: 8714484. DOI: 10.3724/zdxbyxb-2021-0263.

Prolonged thrombocytopenia in a neonate with Noonan syndrome: a case report.

Li M, Zhang J, Sun N J Int Med Res. 2020; 48(8):300060520936445.

PMID: 32867556 PMC: 7469734. DOI: 10.1177/0300060520936445.

Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.

Athota J, Bhat M, Nampoothiri S, Gowrishankar K, Narayanachar S, Puttamallesh V BMC Med Genet. 2020; 21(1):50.

PMID: 32164556 PMC: 7068896. DOI: 10.1186/s12881-020-0986-5.

References

van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E . Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet. 1994; 53(2):187-91. DOI: 10.1002/ajmg.1320530213. View

van der Burgt I . Noonan syndrome. Orphanet J Rare Dis. 2007; 2:4. PMC: 1781428. DOI: 10.1186/1750-1172-2-4. View

Neri G, Allanson J, Kavamura M . No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes. J Med Genet. 2008; 45(12):832. DOI: 10.1136/jmg.2008.063263. View

Tartaglia M, Cordeddu V, Chang H, Shaw A, Kalidas K, Crosby A . Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. Am J Hum Genet. 2004; 75(3):492-7. PMC: 1182027. DOI: 10.1086/423493. View

Bertola D, Pereira A, Albano L, de Oliveira P, Kim C, Krieger J . PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype. Genet Test. 2006; 10(3):186-91. DOI: 10.1089/gte.2006.10.186. View

Romano A, Allanson J, Dahlgren J, Gelb B, Hall B, Pierpont M . Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010; 126(4):746-59. DOI: 10.1542/peds.2009-3207. View

Tartaglia M, Kalidas K, Shaw A, Song X, Musat D, van der Burgt I . PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002; 70(6):1555-63. PMC: 379142. DOI: 10.1086/340847. View

Essawi M, Ismail M, Afifi H, Kobesiy M, El Kotoury A, Barakat M . Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome. J Formos Med Assoc. 2013; 112(11):707-12. DOI: 10.1016/j.jfma.2012.06.002. View

Schwarz J, Rodelsperger C, Schuelke M, Seelow D . MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010; 7(8):575-6. DOI: 10.1038/nmeth0810-575. View

10.

Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W . Genotype-phenotype correlations in Noonan syndrome. J Pediatr. 2004; 144(3):368-74. DOI: 10.1016/j.jpeds.2003.11.032. View

11.

Tartaglia M, Mehler E, Goldberg R, Zampino G, Brunner H, Kremer H . Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001; 29(4):465-8. DOI: 10.1038/ng772. View

12.

Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P . A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-9. PMC: 2855889. DOI: 10.1038/nmeth0410-248. View

13.

Jongmans M, Sistermans E, Rikken A, Nillesen W, Tamminga R, Patton M . Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature. Am J Med Genet A. 2005; 134A(2):165-70. DOI: 10.1002/ajmg.a.30598. View

14.

Jorge A, Malaquias A, Arnhold I, Mendonca B . Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway. Horm Res. 2009; 71(4):185-93. DOI: 10.1159/000201106. View

15.

Jongmans M, Otten B, Noordam K, van der Burgt I . Genetics and variation in phenotype in Noonan syndrome. Horm Res. 2004; 62 Suppl 3:56-9. DOI: 10.1159/000080500. View

16.

Duncan W, FOWLER R, FARKAS L, Ross R, WRIGHT A, Bloom K . A comprehensive scoring system for evaluating Noonan syndrome. Am J Med Genet. 1981; 10(1):37-50. DOI: 10.1002/ajmg.1320100106. View

17.

Papadopoulou A, Issakidis M, Gole E, Kosma K, Fryssira H, Fretzayas A . Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment. Eur J Pediatr. 2011; 171(1):51-8. DOI: 10.1007/s00431-011-1487-5. View

18.

Musante L, Kehl H, Majewski F, Meinecke P, Schweiger S, Gillessen-Kaesbach G . Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet. 2003; 11(2):201-6. DOI: 10.1038/sj.ejhg.5200935. View

19.

Mendez H, Opitz J . Noonan syndrome: a review. Am J Med Genet. 1985; 21(3):493-506. DOI: 10.1002/ajmg.1320210312. View

20.

Simsek-Kiper P, Alanay Y, Gulhan B, Lissewski C, Turkyilmaz D, Alehan D . Clinical and molecular analysis of RASopathies in a group of Turkish patients. Clin Genet. 2012; 83(2):181-6. DOI: 10.1111/j.1399-0004.2012.01875.x. View